Sophia Debt To Equity from 2010 to 2025
| SOPH Stock | USD 4.60 0.27 5.54% |
Debt To Equity | First Reported 2010-12-31 | Previous Quarter 0.31122396 | Current Value 0.19 | Quarterly Volatility 0.08120399 |
Check Sophia Genetics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Sophia Genetics' main balance sheet or income statement drivers, such as Tax Provision of 1.3 M, Net Interest Income of 1.5 M or Interest Income of 1.7 M, as well as many indicators such as Price To Sales Ratio of 2.96, Dividend Yield of 0.0 or PTB Ratio of 2.0. Sophia financial statements analysis is a perfect complement when working with Sophia Genetics Valuation or Volatility modules.
Sophia | Debt To Equity | Build AI portfolio with Sophia Stock |
Currently Active Assets on Macroaxis
| PRNEX | T Rowe Price | |
| RPBAX | T Rowe Price | |
| PRDGX | T Rowe Price | |
| PRFDX | T Rowe Price | |
| RPBAX | T Rowe Price |
Check out the analysis of Sophia Genetics Correlation against competitors. You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Sophia Genetics. If investors know Sophia will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Sophia Genetics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.12) | Revenue Per Share | Quarterly Revenue Growth 0.228 | Return On Assets | Return On Equity |
The market value of Sophia Genetics SA is measured differently than its book value, which is the value of Sophia that is recorded on the company's balance sheet. Investors also form their own opinion of Sophia Genetics' value that differs from its market value or its book value, called intrinsic value, which is Sophia Genetics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Sophia Genetics' market value can be influenced by many factors that don't directly affect Sophia Genetics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Sophia Genetics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Sophia Genetics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Sophia Genetics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.